Clinical Trials Logo

Filter by:
NCT ID: NCT06387134 Recruiting - Clinical trials for Early Stage Lung Adenocarcinoma

Lifei Xiaoji Wan Treatment's of Early-stage NSCLC and Its Impact on the Tumor Microenvironment

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

This study evaluated the relationship between the clinical efficacy, histopathological changes and tumor microenvironment of the pharmacopharmacologic Lifei Xiaoji Wan in the treatment of early stage lung adenocarcinoma, and improved high-level clinical evidence and action targets for the prevention and treatment of early stage lung cancer by traditional Chinese medicine

NCT ID: NCT06387056 Recruiting - Clinical trials for Oligometastatic Prostate Cancer

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

SEGNO
Start date: April 1, 2024
Phase: Phase 2
Study type: Interventional

To evaluated the safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer.

NCT ID: NCT06386705 Recruiting - Malignant Neoplasm Clinical Trials

A Study of TSN084 in Patients With Advanced Malignant Tumors

Start date: July 20, 2022
Phase: Phase 1
Study type: Interventional

TSN084 is a novel type II kinase inhibitor with demonstrated anti-tumor effects in vitro and in vivo and targets multiple tyrosine kinases, such as c-MET, FLT3, TRK and serine/threonine kinase CDK8/19. This phase 1a/1b study is conducted to assess the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT), to evaluate the pharmacokinetics, safety and preliminary anti-tumor activity of TSN084 in advanced or metastatic malignancies in China.

NCT ID: NCT06386614 Recruiting - Stroke Clinical Trials

Effects of TDCS of the Frontal Lobe on Cognitive Function and BDNF in PSCI

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The purpose of the clinical trial is to find a treatment for stroke patients with cognitive impairment, and the main questions it aims to answer are: - [Search for effective treatments of cognitive impairment after stroke] - [explore the relationship between BDNF level and cognitive function] Participants will receive conventional treatment, tDCS treatment, .And then compare cognitive function and BDNF level

NCT ID: NCT06386549 Recruiting - Burns Clinical Trials

Effect of a Tele-rehabilitation Programme in Children With Burns: a Randomized Controlled Trial

Start date: November 14, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare tele-rehabilitation and routine post-discharge rehabilitation in children with burn injuries. The main questions it aims to answer are: - Is tele-rehabilitation better for improving the quality and outcomes of care for burn children? - Is tele-rehabilitation more effective in improving scar management in children with burns injuries? - Is tele-rehabilitation more effective in improving perceived stress in parents of children with burns injuries?

NCT ID: NCT06386458 Completed - Atrial Fibrillation Clinical Trials

Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access

Start date: July 8, 2022
Phase: N/A
Study type: Interventional

This study is a prospective, multicenter, randomized controlled trial with a non-inferiority design. Participants are patients scheduled for atrial septal puncture. After signing informed consent, subjects will be randomly assigned to either the radiofrequency transseptal puncture system group (referred to as the trial group) or the traditional mechanical transseptal puncture system group (referred to as the control group). All participants will undergo immediate postoperative and discharge clinical follow-ups.

NCT ID: NCT06386159 Recruiting - Clinical trials for Post-extubation Dysphagia

Clinical Application of Comprehensive Intervention for PED Based on Neuroregulatory Mechanism

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

This study aims to establish a practical comprehensive intervention program for dysphagia after extubation in adult ICU patients based on the best evidence of its assessment and intervention, through expert panel discussion and Delphi method. In addition, combining the preliminary experimental results of vagus nerve stimulation applied to PED patients, we further develop a comprehensive intervention program for dysphagia after extubation based on neural regulation mechanism. Finally, the implementation effect of this PED comprehensive intervention program based on neural regulation mechanism will be verified through clinical application.

NCT ID: NCT06386016 Recruiting - Clinical trials for Valvular Heart Disease

Detection of Valvular Heart Disease Using Artificial Intelligence-based Stethoscope

Start date: May 1, 2024
Phase:
Study type: Observational

The aim of this study is to develop a deep learning-based application of heart sounds in the diagnosis of valvular heart disease, which can be used to screen patients with valvular heart disease and promote earlier clinical monitoring and intervention.

NCT ID: NCT06385990 Recruiting - Clinical trials for Triple Negative Breast Neoplasms

Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Start date: March 29, 2024
Phase: Phase 2
Study type: Interventional

This trial is a multicenter, single-arm clinical trial to evaluate the efficacy and safety of UTD1 in combination with capecitabine for the adjuvant treatment of TNBC patients who did not achieve pathologic complete remission after neoadjuvant therapy. TNBC patients who did not achieve pathological complete remission or positive lymph node after neoadjuvant chemotherapy received adjuvant treatment with study drug. Solution: UTD1 30mg / m², once a day on days 1-5; capecitabine: 1000mg / m², days 1-14, oral, twice / day; 21 days a treatment cycle of 6-8 cycles.

NCT ID: NCT06385977 Recruiting - Clinical trials for Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Risk Factors for Chronic Prostatitis Patients in Northwest China

Start date: January 2016
Phase:
Study type: Observational

The goal of this observational study is to learn about the risk factors of lifestyle, medication and sexual habits in adult chronic prostatitis / chronic pelvic pain syndrome patients. The main questions it aims to answer are: - Is lifestyle, medication, and sexual habits related to chronic prostatitis / chronic pelvic pain syndrome - Is there any medication available to protect men from chronic prostatitis / chronic pelvic pain syndrome. Participants will: - Independently receive a survey questionnaire on lifestyle, medication, and sexual habits. - Symptomatic individuals will undergo additional prostate fluid examination for diagnosis. Researchers will compare healthy adult males to see if there are differences on lifestyle, medication and sexual habits between the two groups.